Literature DB >> 31220516

Analysis of FAM19A2/TAFA-2 function.

Junichi Okada1, Eijiro Yamada2, Tsugumichi Saito2, Atsushi Ozawa3, Yasuyo Nakajima2, Jeffrey E Pessin4, Shuichi Okada5, Masanobu Yamada3.   

Abstract

FAM19A2/TAFA-2, a member of the chemokine CC family, shares 31% sequence identity with MIP-1α, which is known to elevate body temperature and reduce food intake. A single administration of 250 pM of FAM19A2/TAFA-2 to the third ventricle of mice just before the initiation of dark period increased food intake and meal number significantly, but reduced meal size during the dark period. The respiratory exchange rate and energy expenditure were increased significantly during the dark period, while the ambulatory count and vertical activity were not affected. These data suggest that FAM19A2/TAFA-2 participates in the regulation of food intake and metabolic activities.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body temperature; FAM19A2/TAFA-2; Food intake; Metabolic cage

Year:  2019        PMID: 31220516     DOI: 10.1016/j.physbeh.2019.112581

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  3 in total

Review 1.  Molecular Structure, Expression and Role of TAFA4 and its Receptor FPR1 in the Spinal Cord.

Authors:  Sipin Zhu; Xiaoyong Hu; Samuel Bennett; Yuliang Mai; Jiake Xu
Journal:  Front Cell Dev Biol       Date:  2022-05-31

2.  Detection of copy number variants in African goats using whole genome sequence data.

Authors:  Wilson Nandolo; Gábor Mészáros; Maria Wurzinger; Liveness J Banda; Timothy N Gondwe; Henry A Mulindwa; Helen N Nakimbugwe; Emily L Clark; M Jennifer Woodward-Greene; Mei Liu; George E Liu; Curtis P Van Tassell; Benjamin D Rosen; Johann Sölkner
Journal:  BMC Genomics       Date:  2021-05-29       Impact factor: 3.969

3.  Association of Serum FAM19A5 with Cognitive Impairment in Vascular Dementia.

Authors:  Juan Li; Shoulin Li; Yihong Song; Wei Zhou; Xiaohao Zhu; Suo Xu; Yihong Ma; Chunlin Zhu
Journal:  Dis Markers       Date:  2020-08-01       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.